Farmaha, Jaspreet Kaur
James, Jeffrey N.
Frazier, Kyle
Sahajpal, Nikhil Shri
Mondal, Ashis K.
Bloomquist, Doan Tam
Kolhe, Ravindra
Looney, Stephen W.
Bloomquist, Ryan
Article History
Received: 6 October 2022
Revised: 17 December 2022
Accepted: 9 January 2023
First Online: 28 April 2023
Ethics declaration
: The authors declare no conflicts of interest.
: All experiments and methods were performed in accordance with relevant guidelines and regulations. The study design was reviewed and approved by the Institutional Review Board of AU (protocol number 1607808). The study received an expedited review based on applicable federal regulations 45 CFR 46 (DHHS). This study was approved by the Human Subjects Ethics Board of AU and was conducted in accordance with the Helsinki Declaration of 1975 as revised in 2013.
: Informed consent was obtained from all subjects and all subjects were able to consent for themselves. All subjects consented accordingly, approved of their own participation and were able to withdraw from the study if desired at any time.
: This clinical trial was registered at ClinicalTrials.gov. The registration number is NCT04719208.
Free to read: This content has been made available to all.